Back to Newsroom
Back to Newsroom

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm

Tuesday, 19 March 2024 07:00 AM

The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / March 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BioVie Inc. ("BioVie" or "the Company") (NASDAQ:BIVI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between August 5, 2021 and November 29, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before March 19, 2024.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. BioVie failed to conduct proper oversight of its Phase 3 clinical trial of NE3107. The Company's oversight efforts were hampered by the COVID-19 pandemic. The Company's reliance on contract research organizations and failure to maintain proper oversight increased the risk of unreliable data in the clinical trial. The clinical trial failed to meet its primary endpoints in part due to the Company's lack of oversight. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about BioVie, investors suffered damages.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

The Schall Law Firm
Brian Schall, Esq.
Office: 310-301-3335
[email protected]

SOURCE: The Schall Law Firm

Class Action
Back to newsroom
Back to Newsroom
Share by: